FY2023 Earnings Forecast for Pacific Biosciences of California, Inc. (NASDAQ:PACB) Issued By Cantor Fitzgerald
Pacific Biosciences of California, Inc. (NASDAQ:PACB – Free Report) – Analysts at Cantor Fitzgerald reduced their FY2023 earnings per share estimates for Pacific Biosciences of California in a research report issued to clients and investors on Wednesday, November 1st. Cantor Fitzgerald analyst R. Osborn now forecasts that the biotechnology company will post earnings of ($1.18) […]
More Stories
GeneDx (NASDAQ:WGS) Stock Price Down 5.6% – Time to Sell?
Shares of GeneDx Holdings Corp. (NASDAQ:WGS – Get Free Report) fell 5.6% during trading on Monday . The company traded...
Palantir Technologies (NYSE:PLTR) Stock Price Down 2.5% – Should You Sell?
Palantir Technologies Inc. (NYSE:PLTR – Get Free Report)’s share price was down 2.5% during trading on Monday . The stock...
Fluence Energy (NASDAQ:FLNC) Trading 9.5% Higher – Should You Buy?
Fluence Energy, Inc. (NASDAQ:FLNC – Get Free Report) shares were up 9.5% on Monday . The stock traded as high...
Fox Factory (NASDAQ:FOXF) Sees Large Volume Increase – Here’s Why
Fox Factory Holding Corp. (NASDAQ:FOXF – Get Free Report) shares saw strong trading volume on Monday . 1,130,511 shares were...
Deere & Company (NYSE:DE) Stock Price Expected to Rise, Citigroup Analyst Says
Deere & Company (NYSE:DE – Get Free Report) had its price objective increased by research analysts at Citigroup from $460.00...
High Blood Sugar Linked to Impaired Brain Activity in Healthy People
By George Citroner A study published in October in Neurobiology of Aging and conducted by Baycrest Academy for Research and...